R. Sultana

发表

Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2006, Neurobiology of Aging.

Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE,in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease

Maurizio Memo, M. Memo, D. Butterfield, 2008, Journal of cellular and molecular medicine.

Low molecular weight thiol amides attenuate MAPK activity and protect primary neurons from Aβ(1–42) toxicity

D. Butterfield, R. Sultana, Orit Bartov, 2006, Brain Research.

Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease.

D. Butterfield, R. Sultana, W. Pierce, 2010, Antioxidants & redox signaling.

Quantitative Proteomic Analysis of Differentially Expressed Proteins in Aβ(17-42) Treated Synaptosomes

R. Sultana, Tanea T Reed, Jaffer Mohammed, 2011 .

Acrolein induces selective protein carbonylation in synaptosomes

D. Butterfield, R. Sultana, J. Klein, 2007, Neuroscience.

Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats.

Michael Goodman, Jason M Unrine, Eric A Grulke, 2012, Toxicological sciences : an official journal of the Society of Toxicology.

Biomarkers of Oxidative Stress in Neurodegenerative Diseases

D. Butterfield, R. Sultana, G. Cenini, 2013 .

Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment.

Mihail I Mitov, D. Butterfield, R. Sultana, 2014, Free radical biology & medicine.

Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction.

D. Butterfield, R. Sultana, D. S. St. Clair, 2010, Advances in experimental medicine and biology.

Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: Insight into chemobrain

D. Butterfield, R. Sultana, S. Estus, 2005, Free radical research.

Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice

D. Butterfield, R. Sultana, D. S. St. Clair, 2006, Molecular Cancer Therapeutics.

Glutathione elevation by γ‐glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain

D. Butterfield, R. Sultana, G. Joshi, 2007, Journal of neuroscience research.

Adriamycin‐mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain

D. Butterfield, R. Sultana, S. Estus, 2007, Journal of neurochemistry.

Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease

D. Butterfield, R. Sultana, W. Pierce, 2008, Neurobiology of Disease.

Lack of p 53 Affects the Expression of Several Brain Mitochondrial Proteins : Insights from Proteomics into Important Pathways Regulated by p 53

D. Butterfield, R. Sultana, Jian Cai, 2017 .

Lack of p53 Affects the Expression of Several Brain Mitochondrial Proteins: Insights from Proteomics into Important Pathways Regulated by p53

D. Butterfield, R. Sultana, Jian Cai, 2012, PloS one.

The wheat germ agglutinin‐fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression

D. Butterfield, R. Sultana, Jian Cai, 2010, Journal of neuroscience research.

Plasma and Serum Proteins Bound to Nanoceria: Insights into Pathways by which Nanoceria may Exert Its Beneficial and Deleterious Effects In Vivo

R. Sultana, Jian Cai, W. Pierce, 2020, Journal of nanomedicine & nanotechnology.

Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.

D. Butterfield, R. Sultana, Jian Cai, 2012, Antioxidants & redox signaling.

Sex differences in brain proteomes of neuron‐specific STAT3‐null mice after cerebral ischemia/reperfusion

R. Sultana, Jian Cai, W. Pierce, 2012, Journal of neurochemistry.

Increase in Mrp 1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C 57 BL / 6 mice

D. Butterfield, R. Sultana, M. P. Cole, 2006 .

Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain.

D. Butterfield, R. Sultana, M. Murphy, 2012, The international journal of neuropsychopharmacology.

Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer disease subjects

D. Butterfield, R. Sultana, Jian Cai, 2011 .

Potential in vivo amelioration by N‐acetyl‐L‐cysteine of oxidative stress in brain in human double mutant APP/PS‐1 knock‐in mice: Toward therapeutic modulation of mild cognitive impairment

D. Butterfield, R. Sultana, W. Markesbery, 2010, Journal of neuroscience research.

Detection of 4-hydroxy-2-nonenal- and 3-nitrotyrosine-modified proteins using a proteomics approach.

D. Butterfield, R. Sultana, Tanea T Reed, 2009, Methods in molecular biology.

N VIVO PROTECTION BY THE XANTHATE TRICYCLODECAN-9-YL-ANTHOGENATE AGAINST AMYLOID-PEPTIDE ( 1 – 42 )-INDUCED XIDATIVE STRESS

R. Sultana, C. D. Marco, G. Joshi, 2006 .

Formation of acetaldehyde adducts of glutathione S-transferase A3 in the liver of rats administered alcohol chronically.

R. Sultana, P. Reddanna, Varsha Sharma, 2005, Alcohol.

In vivo protection of synaptosomes from oxidative stress mediated by Fe2+/H2O2 or 2,2-azobis-(2-amidinopropane) dihydrochloride by the glutathione mimetic tricyclodecan-9-yl-xanthogenate.

D. Butterfield, R. Sultana, G. Joshi, 2005, Free radical biology & medicine.

Original Contribution In vivo protection of synaptosomes from oxidative stress mediated by Fe 2+ /H 2 O 2 or 2,2-azobis-(2-amidinopropane) dihydrochloride by the glutathione mimetic tricyclodecan-9-yl-xanthogenate

D. Butterfield, R. Sultana, G. Joshi, 2005 .

Protective Effect of the Xanthate, D609, on Alzheimer's Amyloid β-peptide (1–42)-induced Oxidative Stress in Primary Neuronal Cells

R. Sultana, Shelley F. Newman, Jeffery N. Keller, 2004, Free radical research.

Neurotoxicity and oxidative stress in D1M-substituted Alzheimer's Aβ(1-42): relevance to N-terminal methionine chemistry in small model peptides

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2005, Peptides.

Slot-blot analysis of 3-nitrotyrosine-modified brain proteins.

D. Butterfield, R. Sultana, D. Butterfield, 2008, Methods in enzymology.

Identification of 3-nitrotyrosine-modified brain proteins by redox proteomics.

D. Butterfield, R. Sultana, 2008, Methods in enzymology.

Difluoromethylornithine decreases long-lasting protein oxidation induced by neonatal ethanol exposure in the hippocampus of adolescent rats.

D. Butterfield, R. Sultana, C. F. Mello, 2007, Alcoholism, clinical and experimental research.

Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.

D. Butterfield, R. Sultana, W. Markesbery, 2008, Free radical biology & medicine.

14 BIOMARKERS OF OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES

R. Sultana, A. Butterfield, Giovanna CENlNI, 2013 .

Redox modulation of heat shock protein expression by acetylcarnitine in aging brain: relationship to antioxidant status and mitochondrial function.

D. Butterfield, R. Sultana, V. Calabrese, 2006, Antioxidants & redox signaling.

Elevation of mitochondrial glutathione by γ‐glutamylcysteine ethyl ester protects mitochondria against peroxynitrite‐induced oxidative stress

D. Butterfield, R. Sultana, V. Calabrese, 2003, Journal of neuroscience research.

Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress.

D. Butterfield, R. Sultana, V. Calabrese, 2004, Antioxidants & redox signaling.

Do proteomics analyses provide insights into reduced oxidative stress in the brain of an Alzheimer disease transgenic mouse model with an M631L amyloid precursor protein substitution and thereby the importance of amyloid-beta-resident methionine 35 in Alzheimer disease pathogenesis?

D. Butterfield, R. Sultana, Jian Cai, 2012, Antioxidants & redox signaling.

Differential Expression and Redox Proteomics Analyses of an Alzheimer Disease Transgenic Mouse Model: Effects of the Amyloid-β Peptide of APPΞ

D. Butterfield, R. Sultana, Jian Cai, 2011 .

Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway

T. Murphy, D. Butterfield, G. Bell, 2010, Proceedings of the National Academy of Sciences.

Effects of apolipoprotein E on the human immunodeficiency virus protein tat in neuronal cultures and synaptosomes

D. Butterfield, R. Martins, R. Sultana, 2004, Journal of neuroscience research.

Lack of p 53 Decreases Basal Oxidative Stress Levels in the Brain Through Upregulation of Thioredoxin-1 , Biliverdin Reductase-A , Manganese Superoxide Dismutase , and Nuclear Factor Kappa-B

D. Butterfield, R. Sultana, Chi Wang, 2012 .

Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B.

D. Butterfield, R. Sultana, Chi Wang, 2012, Antioxidants & redox signaling.

In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane)dihydrochloride (AAPH) or Fe2+/H2O2: Insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders

D. Butterfield, R. Sultana, G. Joshi, 2006, Neurochemistry International.

Nutritional approaches to modulate oxidative stress in Alzheimer's disease.

D. Butterfield, R. Sultana, C. Pocernich, 2011, Current Alzheimer research.

γ‐glutamylcysteine ethyl ester‐induced up‐regulation of glutathione protects neurons against Aβ(1–42)‐mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2005 .

Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2005, Journal of neuroscience research.

Alteration of hepatic structure and oxidative stress induced by intravenous nanoceria.

D. Butterfield, R. Sultana, E. Grulke, 2012, Toxicology and applied pharmacology.

Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

D. Butterfield, R. Sultana, Tanea T Reed, 2007 .

In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid β-peptide (1–42)-induced oxidative stress

D. Butterfield, R. Sultana, G. Joshi, 2006, Neuroscience.

Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.

D. Butterfield, R. Sultana, C. Mancuso, 2012, Free radical biology & medicine.

Cell Cycle Proteins in Brain in Mild Cognitive Impairment: Insights into Progression to Alzheimer Disease

Mihail I Mitov, D. Butterfield, R. Sultana, 2012, Neurotoxicity Research.

Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.

D. Butterfield, R. Sultana, M. Perluigi, 2013, Free radical biology & medicine.

Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment

D. Butterfield, R. Sultana, R. Coccia, 2006, Neuroscience Letters.

Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics.

D. Butterfield, R. Sultana, M. Perluigi, 2006, Antioxidants & redox signaling.

Brain distribution and toxicological evaluation of a systemically delivered engineered nanoscale ceria.

Jason M Unrine, Eric A Grulke, Robert A Yokel, 2010, Toxicological sciences : an official journal of the Society of Toxicology.

Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders.

R. Sultana, 2012, Biochimica et biophysica acta.

Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

D. Butterfield, R. Sultana, M. Perluigi, 2012, Antioxidants & redox signaling.

Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder.

D. Butterfield, P. Mecocci, R. Sultana, 2011, Journal of Alzheimer's disease : JAD.

Role of oxidative stress in the progression of Alzheimer's disease.

D. Butterfield, R. Sultana, 2010, Journal of Alzheimer's disease : JAD.

Proteomic identification of proteins oxidized by Aβ(1–42) in synaptosomes: Implications for Alzheimer's disease

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2005, Brain Research.

Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes

D. Butterfield, R. Sultana, H. Poon, 2005 .

Antisense directed at the Aβ region of APP decreases brain oxidative markers in aged senescence accelerated mice

D. Butterfield, W. Banks, R. Sultana, 2004, Brain Research.

In Vivo Processing of Ceria Nanoparticles inside Liver: Impact on Free-Radical Scavenging Activity and Oxidative Stress.

Jason M Unrine, Eric A Grulke, Robert A Yokel, 2014, ChemPlusChem.

Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies.

D. Butterfield, R. Sultana, D. Butterfield, 2012, Journal of Alzheimer's disease : JAD.

Redox proteomics studies of in vivo amyloid beta‐peptide animal models of Alzheimer's disease: Insight into the role of oxidative stress

D. Butterfield, R. Sultana, 2008, Proteomics. Clinical applications.

Redox Proteomics: A New Approach to Investigate Oxidative Stress in Alzheimer's Disease

D. Butterfield, R. Sultana, H. Poon, 2006 .

Proteomics Identification of Oxidatively Modified Proteins in the Alzheimer’s Disease Brain and Models Thereof: Insights into Potential Mechanisms of Neurodegeneration

D. Butterfield, R. Sultana, H. Poon, 2005 .

Chapter 32 SAMP 8 : A model to understand the role of oxidative stress in age-related diseases including Alzheimer ’ s disease

D. Butterfield, R. Sultana, G. Cenini, 2012 .

Research report Antisense directed at the Ah region of APP decreases brain oxidative markers in aged senescence accelerated mice

D. Butterfield, W. Banks, R. Sultana, 2004 .

Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.

D. Butterfield, W. Banks, R. Sultana, 2004, Brain research.

Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease

D. Butterfield, R. Sultana, Jian Cai, 2015, Journal of neurochemistry.

2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain.

D. Butterfield, R. Sultana, Jian Cai, 2011, Free radical biology & medicine.

In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders.

D. Butterfield, R. Sultana, M. Ansari, 2006, Free radical biology & medicine.

Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.

D. Butterfield, R. Sultana, M. Lange, 2010, Biochimica et biophysica acta.

In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.

D. Butterfield, R. Sultana, D. Bredesen, 2010, Free radical biology & medicine.

Redox proteomics identification of 4‐hydroxynonenal‐modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis

M. Memo, D. Butterfield, R. Sultana, 2009, Proteomics. Clinical applications.

Glutathionylation of the Pro-apoptotic Protein p53 in Alzheimer’s Disease Brain: Implications for AD Pathogenesis

M. Memo, D. Butterfield, R. Sultana, 2009, Neurochemical Research.

Protein Levels and Activity of Some Antioxidant Enzymes in Hippocampus of Subjects with Amnestic Mild Cognitive Impairment

D. Butterfield, R. Sultana, M. Piroddi, 2008, Neurochemical Research.

An increase in S‐glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach

D. Butterfield, R. Sultana, Jian Cai, 2007, Journal of neuroscience research.

Oxidatively Modified GST and MRP1 in Alzheimer’s Disease Brain: Implications for Accumulation of Reactive Lipid Peroxidation Products

D. Butterfield, R. Sultana, 2004, Neurochemical Research.

Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)—2′,3′-dideoxycytidine (ddC): Relevance to HIV-dementia

D. Butterfield, R. Sultana, M. Ansari, 2007, Experimental Neurology.

Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.

R. Sultana, Sarah M. Wilson, R. Khanna, 2012, Future neurology.

Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury.

Vidya N. Nukala, D. Butterfield, R. Sultana, 2007, Journal of neurotrauma.

Adriamycin-induced, TNF-α-mediated central nervous system toxicity

D. Butterfield, R. Sultana, W. Clair, 2006, Neurobiology of Disease.

Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity.

D. Butterfield, R. Sultana, S. Estus, 2006, Neurobiology of disease.

Regional Expression of Key Cell Cycle Proteins in Brain from Subjects with Amnestic Mild Cognitive Impairment

D. Butterfield, R. Sultana, 2007, Neurochemical Research.

Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease

D. Butterfield, R. Sultana, Xiao Zhen Zhou, 2015, Neurobiology of Disease.

Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).

D. Butterfield, R. Sultana, M. Perluigi, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

In vivo protective effects of ferulic acid ethyl ester against amyloid‐beta peptide 1–42‐induced oxidative stress

D. Butterfield, R. Sultana, G. Joshi, 2006, Journal of neuroscience research.

Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

D. Butterfield, R. Sultana, Aaron M. Swomley, 2013, Antioxidants & redox signaling.

Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder.

D. Butterfield, R. Sultana, D. A. Butterfield, 2007 .

REVIEW: Pin1 in Alzheimer's disease

D. Butterfield, R. Sultana, M. Ansari, 2006, Journal of neurochemistry.

Involvement of stat3 in mouse brain development and sexual dimorphism: A proteomics approach

D. Butterfield, R. Sultana, Jian Cai, 2010, Brain Research.

Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.

D. Butterfield, R. Sultana, G. Cenini, 2011, Biochimica et biophysica acta.

Ferulic acid ethyl ester protects neurons against amyloid β‐ peptide(1–42)‐induced oxidative stress and neurotoxicity: relationship to antioxidant activity

D. Butterfield, R. Sultana, V. Calabrese, 2005, Journal of neurochemistry.

Alumina nanoparticles induce expression of endothelial cell adhesion molecules.

Bernhard Hennig, Nitin Chopra, D. Butterfield, 2008, Toxicology letters.

An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach.

D. Butterfield, R. Sultana, Jian Cai, 2014, Free radical biology & medicine.

Vitamin E is essential for Purkinje neuron integrity

D. Butterfield, R. Sultana, D. Manor, 2014, Neuroscience.

Identification of the oxidative stress proteome in the brain.

D. Butterfield, R. Sultana, D. Butter, 2011, Free radical biology & medicine.

Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease

D. Butterfield, R. Sultana, Tanea T Reed, 2011, Free radical research.

Redox Proteomics of Oxidatively Modified Brain Proteins in Mild Cognitive Impairment

D. Butterfield, R. Sultana, Tanea T Reed, 2010 .

Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

D. Butterfield, R. Sultana, M. Perluigi, 2009, Acta Neuropathologica.

Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease.

D. Butterfield, R. Sultana, 2009, Methods in molecular biology.

Proteomics identification of oxidatively modified proteins in brain.

D. Butterfield, R. Sultana, M. Perluigi, 2009, Methods in molecular biology.

Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1–42) into rat brain: Implications for Alzheimer’s disease

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2005, Neuroscience.

HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations

D. Allan Butterfield, Avindra Nath, D. Butterfield, 2005, Brain Research Reviews.

Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2004, Journal of Alzheimer's disease : JAD.

Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease.

D. Butterfield, R. Sultana, M. Murphy, 2014, Free radical biology & medicine.

Oxidative modification of lipoic acid by HNE in Alzheimer disease brain☆

D. Butterfield, R. Sultana, M. Murphy, 2013, Redox biology.

Original Contribution

D. Butterfield, R. Sultana, Jian Cai, 2022 .

Apolipoprotein A‐I: Insights from redox proteomics for its role in neurodegeneration

D. Butterfield, R. Sultana, S. Förster, 2013, Proteomics. Clinical applications.

Proteomics analysis of the Alzheimer's disease hippocampal proteome.

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2007, Journal of Alzheimer's disease : JAD.

Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid beta-peptide.

D. Butterfield, R. Sultana, 2008, Molecular bioSystems.

Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain

D. Butterfield, R. Sultana, G. Joshi, 2010, Neuroscience.

Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.

Jian Cai, D. Butterfield, R. Sultana, 2011, Journal of proteomics.

Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study

D. Butterfield, R. Sultana, W. Pierce, 2007, Journal of cellular and molecular medicine.

γ‐Glutamylcysteine ethyl ester protection of proteins from Aβ(1–42)‐mediated oxidative stress in neuronal cell culture: A proteomics approach

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2005, Journal of neuroscience research.

Oxidative Stress in Alzheimer's Disease Brain: New Insights from Redox Proteomics

D. Butterfield, R. Sultana, M. Perluigi, 2006 .

Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach

D. Butterfield, R. Sultana, H. Poon, 2006, Neurobiology of Disease.

Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease.

Giovanni Scapagnini, Giovanni Pennisi, D. Butterfield, 2006, Antioxidants & redox signaling.

Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: An investigation on the role of cellular stress response in the progression of Alzheimer disease

D. Butterfield, R. Sultana, F. Di Domenico, 2010, Brain Research.

Biliverdin reductase‐A: a novel drug target for atorvastatin in a dog pre‐clinical model of Alzheimer disease

D. Butterfield, R. Sultana, M. Murphy, 2012, Journal of neurochemistry.

Research report Proteomic identification of proteins oxidized by Ah(1-42) in synaptosomes: Implications for Alzheimer's disease

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2005 .

Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.

D. Butterfield, R. Sultana, G. Cenini, 2011, Journal of Alzheimer's disease : JAD.

Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.

M. Memo, D. Butterfield, R. Sultana, 2008, Free radical biology & medicine.

Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease

D. Butterfield, R. Sultana, W. Markesbery, 2007, Brain Research.

Mutations in amyloid precursor protein and presenilin‐1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β‐peptide (1–42), H2O2 and kainic acid: implications for Alzheimer's disease

D. Butterfield, R. Sultana, W. Markesbery, 2006, Journal of neurochemistry.

Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.

D. Butterfield, R. Sultana, Judy C. Triplett, 2014, Biochimica et biophysica acta.

Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.

D. Butterfield, R. Sultana, M. Murphy, 2011, Pharmacological research.

Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease

M. Memo, D. Butterfield, R. Sultana, 2008, Neurobiology of Disease.

P4-162: Proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: Insights into the progression of this dementing disorder

D. Butterfield, R. Sultana, 2008, Alzheimer's & Dementia.

Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment

D. Butterfield, R. Sultana, D. Butterfield, 2009, Journal of bioenergetics and biomembranes.

Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.

D. Butterfield, W. Banks, R. Sultana, 2010, Free radical biology & medicine.

Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”)

D. Butterfield, R. Sultana, D. Powell, 2018, Oncotarget.

Doxorubicin-induced thymus senescence.

D. Butterfield, R. Sultana, Jian Cai, 2010, Journal of proteome research.

Plasma TNF-α and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna—A Randomized, Cross-Over Clinical Study

D. Butterfield, R. Sultana, H. Weiss, 2015, PloS one.

Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity

D. Butterfield, R. Sultana, E. Grulke, 2014, Nanotoxicology.

Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s disease

W. Banks, R. Sultana, G. Shah, 2009, Brain, Behavior, and Immunity.

Author ' s personal copy Lipopolysaccharide alters the blood – brain barrier transport of amyloid b protein : A mechanism for inflammation in the progression of Alzheimer ’ s disease

W. Banks, R. Sultana, G. Shah, 2009 .

Redox Proteomics Identification of Oxidatively Modified Proteins in Alzheimer’s Disease Brain and in Brain from a Rodent Model of Familial Parkinson’s Disease: Insights into Potential Mechanisms of Neurodegeneration

D. Butterfield, R. Sultana, H. Poon, 2008 .

Cell Cycle Proteins in Brain in Mild Cognitive Impairment: Insights into Progression to Alzheimer Disease

D. Allan Butterfield, D. Butterfield, R. Sultana, 2011, Neurotoxicity Research.

Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

D. Butterfield, R. Sultana, Tanea T Reed, 2007, Free radical biology & medicine.

Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease.

D. Butterfield, P. Mecocci, R. Sultana, 2013, Free radical biology & medicine.

Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study.

D. Butterfield, R. Sultana, Jian Cai, 2013, Free radical biology & medicine.

Proteomic analysis of brain proteins in APP/PS‐1 human double mutant knock‐in mice with increasing amyloid β‐peptide deposition: Insights into the effects of in vivo treatment with N‐acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease

D. Butterfield, R. Sultana, Jian Cai, 2011, Proteomics.

Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor proteinΞ

D. Butterfield, R. Sultana, W. Pierce, 2011, Neuroscience.

Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis

D. Allan Butterfield, D. Butterfield, R. Sultana, 2006, Neurobiology of Aging.

Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

D. Butterfield, R. Sultana, W. Pierce, 2009, Journal of proteome research.

Annexin A1 Complex Mediates Oxytocin Vesicle Transport

D. Butterfield, R. Sultana, J. Cai, 2013, Journal of neuroendocrinology.

Pin 1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer ' s disease

Eld, R. Sultana, Xiao Zhen Zhou, 2015 .

Brain Oxidative Stress in the Pathogenesis and Progression of Alzheimer’s Disease

D. Butterfield, R. Sultana, Aaron M. Swomley, 2013 .

Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2004, Chemical research in toxicology.

Biodistribution and oxidative stress effects of a systemically-introduced commercial ceria engineered nanomaterial

Eric A. Grulke, Jason M. Unrine, D. Allan Butterfield, 2009 .

Methionine-35 of Aβ(1–42): Importance for Oxidative Stress in Alzheimer Disease

D. Butterfield, R. Sultana, Allan Butterfield, 2011, Journal of amino acids.

Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.

D. Butterfield, R. Sultana, Judy C. Triplett, 2014, Biochimica et biophysica acta.

Ephrin Bs and canonical Reelin signalling

Joachim Herz, Theresa Pohlkamp, R. Sultana, 2016, Nature.

Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.

D. Butterfield, R. Sultana, Jian Cai, 2011, Journal of proteomics.

Brain Protein Oxidation and Modification for Good or for Bad in Alzheimer’s Disease

D. Butterfield, R. Sultana, D. Butterfield, 2011 .

Nitrated Proteins in the Progression of Alzheimer’s Disease: A Proteomics Comparison of Mild Cognitive Impairment and Alzheimer’s Disease Brain

D. Butterfield, R. Sultana, Renã A. Sowell, 2009 .

Rat brain pro-oxidant effects of peripherally administered 5 nm ceria 30 days after exposure.

D. Butterfield, R. Sultana, E. Grulke, 2012, Neurotoxicology.

Protective effect of D609 against amyloid‐beta1–42‐induced oxidative modification of neuronal proteins: Redox proteomics study

D. Butterfield, R. Sultana, Jian Cai, 2006, Journal of neuroscience research.

Erratum: Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion (Journal of Neurochemistry (2012) 121 (680-692)

R. Sultana, W. Pierce, C. Mancuso, 2012 .

Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor proteinΞ

D. Butterfield, R. Sultana, W. Pierce, 2011, Neuroscience.

Detection of carbonylated proteins in two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis separations.

D. Butterfield, R. Sultana, Quanzhen Huang, 2008, Methods in molecular biology.

Ethanol-induced alteration in N-methyl-d-aspartate receptor 2A C-terminus and protein kinase C activity in rat brain

R. Sultana, P. Babu, 2003, Neuroscience Letters.

Redox proteomics: understanding oxidative stress in the progression of age-related neurodegenerative disorders

D. Butterfield, R. Sultana, 2008, Expert review of proteomics.

Antioxidant activity of X-34 in synaptosomal and neuronal systems

D. Butterfield, W. Klunk, R. Sultana, 2003, Brain Research.

Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.

R. Sultana, M. Perluigi, D. Butterfield, 2006, European journal of pharmacology.

D. Butterfield, R. Sultana, Jian Cai, 2011, Proteomics.

Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease

D. Butterfield, R. Sultana, Tanea T Reed, 2011, Free radical research.

Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain.

D. Butterfield, R. Sultana, G. Cenini, 2012, The international journal of neuropsychopharmacology.

Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.

D. Butterfield, R. Sultana, M. Perluigi, 2013, Free radical biology & medicine.

In Vivo Protective Effects of Ferulic Acid Ethyl Ester against Amyloid-beta Peptide 1–42-induced Oxidative Stress

R. Sultana, G. Joshi, M. Perluigi, 2022 .

Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity

R. Sultana, E. Grulke, U. Graham, 2014, Nanotoxicology.

Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s disease

R. Sultana, Laura B. Jaeger, M. Erickson, 2009, Brain, Behavior, and Immunity.

R. Sultana, M. Ansari, H. Abdul, 2006, Free Radical Biology & Medicine.

In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.

R. Sultana, P. Spilman, Huidong Tang, 2010, Free radical biology & medicine.

Protein Oxidation in Aging and Alzheimer’s Disease Brain

R. Sultana, D. Butterfield, A. N. Carvalho, 2024, Antioxidants.